PharmChem Financials
| PCHM Stock | USD 3.05 0.00 0.00% |
PharmChem |
PharmChem Stock Summary
PharmChem competes with Mesabi Trust, Nutanix, Morningstar Unconstrained, Thrivent High, and Via Renewables. PharmChem, Inc. provides PharmChek Sweat Patch that is used to detect drugs of abuse. Its PharmChek Sweat Patch uses sweat as the source and offers alternative to urine testing for cocaine, opiates, amphetamines, PCP, and marijuana. Pharmchem is traded on OTC Exchange in the United States.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US7171331025 |
| Business Address | 2411 East Loop |
| Sector | Health Care Providers & Services |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.pharmchek.com |
| Phone | 855 458 4100 |
| Currency | USD - US Dollar |
PharmChem Key Financial Ratios
There are many critical financial ratios that PharmChem's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that PharmChem reports annually and quarterly.| Return On Equity | -0.24 | |||
| Return On Asset | -0.0537 | |||
| Number Of Employees | 11 | |||
| Beta | 1.15 | |||
| Z Score | 1.0 |
PharmChem Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining PharmChem's current stock value. Our valuation model uses many indicators to compare PharmChem value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across PharmChem competition to find correlations between indicators driving PharmChem's intrinsic value. More Info.PharmChem is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the PharmChem's earnings, one of the primary drivers of an investment's value.PharmChem Systematic Risk
PharmChem's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. PharmChem volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on PharmChem correlated with the market. If Beta is less than 0 PharmChem generally moves in the opposite direction as compared to the market. If PharmChem Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one PharmChem is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of PharmChem is generally in the same direction as the market. If Beta > 1 PharmChem moves generally in the same direction as, but more than the movement of the benchmark.
PharmChem December 23, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of PharmChem help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of PharmChem. We use our internally-developed statistical techniques to arrive at the intrinsic value of PharmChem based on widely used predictive technical indicators. In general, we focus on analyzing PharmChem Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build PharmChem's daily price indicators and compare them against related drivers.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 18.19 | |||
| Value At Risk | (5.01) | |||
| Potential Upside | 4.17 |
Other Information on Investing in PharmChem Pink Sheet
PharmChem financial ratios help investors to determine whether PharmChem Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PharmChem with respect to the benefits of owning PharmChem security.